Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to its letter dated 11 July 2025 regarding the notice of 38th Annual General Meeting, Hester Biosciences has informed that the record date has been fixed to determine the members entitled to receive the proposed final dividend of INR 7 per equity share (i.e. 70% of the face value of INR 10 each), subject to declaration at the 38th Annual General Meeting, and deduction of applicable tax.
The above information is a part of company’s filings submitted to BSE.
